Prostanozol
From Infogalactic: the planetary knowledge core
 |
|
| Clinical data | |
|---|---|
| Routes of administration |
Oral |
| Identifiers | |
| ATC code | none |
| UNII | JNU1579M5D  |
| Chemical data | |
| Formula | C25H38N2O2 |
| Molecular mass | 398.580 g/mol |
|
|
| (verify) | |
Prostanozol is an anabolic steroid designer drug which is a prodrug of the 17-demethylated analogue of stanozolol (Winstrol). It was found in 2005 as an ingredient of products sold as "dietary supplements" for bodybuilding.[1]
It is one of hundreds of drugs banned from the Olympics by the IOC.[2] Russian marathon runner Lyubov Denisova was banned for two years from competition after testing positive for prostanozol and testosterone in 2007.[3]
References
- ↑ Eenoo PV, Delbeke FT. Metabolism and excretion of anabolic steroids in doping control—New steroids and new insights. Journal of Steroid Biochemistry and Molecular Biology. 2006;101(4-5):161-178. doi:10.1016/j.jsbmb.2006.06.024
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Anabolic steroids
- Tetrahydropyrans
- Designer drugs
- Gastrointestinal system drug stubs
